| Literature DB >> 25203056 |
Zhiping Huang1, Peng Zhang2, Haiqing Wang2, Lunan Yan2, Wentao Wang2.
Abstract
BACKGROUND: Significant hemorrhage together with blood transfusion has negative impact on postoperative morbidity, mortality, and long-term survival of liver resection. Various techniques of vascular occlusion have been developed to reduce intraoperative blood loss. The objective of this study was to compare the outcomes of Pringle maneuver, hemi-hepatic vascular occlusion, and treatment without vascular occlusion used during liver resection.Entities:
Mesh:
Year: 2014 PMID: 25203056 PMCID: PMC4159310 DOI: 10.1371/journal.pone.0107303
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Simple hemi-occlusion.
A: On the visceral envelope overlying the confluence, a small hole was made using a sharp blade; B: A right-angle forceps was inserted to gently mobilize the liver parenchyma outside Glisson’s sheath; C: The right-angle forceps should mobilize in the liver parenchyma towards the caudate lobe; D: A catheter was introduced.
Figure 2Hooking with ligation.
A: The resection line was marked by electrocautery on the hepatic surface, B: The liver was dissected by rightangle forceps hooking the hepatic tissue; C, D, and E: Cannular structures were ligated and cut; F: Right-angle forceps hooked the hepatic tissue forward one by one.
Preoperative characteristic of patients.
| No occlusion group (n = 200) | The Pringle group (n = 158) | The hemi-hepatic group (n = 126) | P value | |
|
| 50.4±12.6 | 48.5±12.0 | 49.3±12.8 | 0.358 |
|
| 175/25 | 129/29 | 187/29 | 0.253 |
|
| 1(1–3) | 1(1–3) | 1(1–3) | 0.573 |
|
| ||||
|
| 24(12.0%) | 31(19.6%) | 31(14.4%) | 0.127 |
|
| 169/31 | 137/21 | 187/29 | 0.783 |
|
| ||||
|
| 155(77.5%) | 134(84.8%) | 169(78.2%) | 0.179 |
|
| 56.8±52.6 | 55.9±45.8 | 58.0±49.4 | 0.918 |
|
| 63.1±70.6 | 62.8±50.6 | 57.5±47.7 | 0.545 |
|
| 40.6±4.6 | 39.4±5.3 | 39.9±4.6 | 0.063 |
|
| 138.5±20.0 | 138.5±22.2 | 140.5±20.0 | 0.516 |
|
| 167.5±80.6 | 163.9±79.8 | 175.3±83.6 | 0.378 |
|
| 6.5±2.4 | 6.1±2.7 | 6.3±2.2 | 0.301 |
IQR: interquartile range; ALT: alanine aminotransferase; AST: aspartate aminotransferase;
HBsAg: antigen of hepatitis B.
Intraoperative data.
| No occlusion group (n = 200) | The Pringle group (n = 158) | The hemi-hepatic group (n = 216) | P value | |
|
| ||||
|
| 91(45.5%) | 68(43.0%) | 114(52.8%) | 0.136 |
|
| 101(50.5%) | 76(48.1%) | 91(42.1%) | 0.213 |
|
| 8(4.0%) | 14(9.9%) | 11(5.1%) | 0.127 |
|
| 0 | 41.9±12.3 | 44.3±18.7 | 0.150 |
|
| 638.2±426.8 | 518.0±451.0 | 513.0±366.7 | 0.03 |
|
| I vs II = 0.906 | |||
| I vs III = 0.001 | ||||
| II vs III = 0.01 | ||||
|
| 45/155(22.5%) | 42/166(26.6%) | 54/162(25.0%) | 0.661 |
|
|
I: Hemi-hepatic group, II: Pringle group, III: No occlusion group.
The postoperative liver function data.
| No occlusion group (n = 200) | The Pringle group (n = 158) | The hemi-hepatic group (n = 216) | P value | |
|
| ||||
|
| 28.0±16.4 | 28.2±15.2 | 30.8±20.0 | 0.209 |
|
| 413.9±415.8 | 409.7±319.8 | 432.5±574.5 | 0.873 |
|
| 392.2±389.7 | 417.5±390.5 | 438.7±623.2 | 0.627 |
|
| 28.4±5.1 | 28.3±5.4 | 28.8±5.6 | 0.560 |
|
| ||||
|
| 33.3±20.4 | 33.5±19.8 | 37.1±31.5 | 0.229 |
|
| 282.1±262.0 | 296.9±243.2 | 281.8±266.9 | 0.827 |
|
| 139.7±123.7 | 151.6±140.6 | 147.0±129.0 | 0.681 |
|
| 31.7±4.1 | 31.2±4.6 | 31.4±5.1 | 0.578 |
|
| ||||
|
| 28.0±24.1 | 28.0±20.8 | 32.1±32.0 | 0.196 |
|
| 127.7±106.1 | 133.2±104.4 | 129.4±111.8 | 0.885 |
|
| 56.4±37.3 | 60.8±40.8 | 66.4±68.3 | 0.141 |
|
| 34.1±4.8 | 34.5±5.6 | 34.8±5.0 | 0.422 |
TBIL: total serum bilirubin; ALT: alanine aminotransferase; AST: aspartate aminotransferase;
Postoperative data.
| No occlusion group (n = 200) | The Pringle group (n = 158) | The hemi-hepatic group (n = 216) | P value | |
|
| 0(0–1) | 0(0–1) | 0(0–1) | 0.604 |
|
| 2(1%) | 6(3.8%) | 5(2.3%) | 0.210 |
|
| 67(33.5) | 54(34.2%) | 92(42.6%) | 0.103 |
|
| 20 | 13 | 19 | |
|
| 23 | 19 | 40 | |
|
| 14 | 11 | 18 | |
|
| 14 | 8 | 15 | |
|
| 0 | 3 | 3 | |
|
| 8 | 5 | 10 | |
|
| 7 | 5 | 9 | |
|
| 1 | 0 | 1 | |
|
| 2 | 6 | 5 |
IQR: interquartile range.
The main Types of complications.
| No occlusion group (n = 200) | The Pringle group (n = 158) | The hemi-hepatic group (n = 216) | |
|
| 9 | 8 | 0 |
|
| 5 | 2 | 8 |
|
| 1 | 5 | 1 |
|
| 15 | 12 | 17 |
|
| 5 | 2 | 6 |
|
| 4 | 5 | 6 |
|
| 3 | 3 | 3 |